| PRD_001069 | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | Formula: | C16 H28 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000291 | Name: | BETA-SECRETASE INHIBITOR NVP-AUR200 | Formula: | C34 H61 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001071 | Name: | N~4~-(2,2-dimethylpropyl)-N~1~-{(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-aspartamide | Formula: | C32 H41 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000292 | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | Formula: | C29 H50 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001075 | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | Formula: | C32 H38 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000330 | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | Formula: | C30 H41 N5 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000332 | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | Formula: | C36 H46 N6 O13 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001107 | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | Formula: | C95 H147 N32 O21 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|
| PRD_001157 | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | Formula: | C51 H69 N10 O11 | Definition date: | 2014-01-15 | Last modified: | 2023-11-03 |
|
| PRD_000377 | Name: | N-(sulfanylacetyl)-D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | Formula: | C23 H36 Cl N6 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000387 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-L-alanyl-N-{(1R)-1-[(S)-[(1S)-2-{[(1R)-1-carboxyethyl]amino}-1-methyl-2-oxoethoxy](hydroxy)phosphoryl]-2-methylpropyl}-L-prolinamide | Formula: | C26 H46 N5 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000395 | Name: | ACE-HAC-ARG-MAA-HAQ-SEL | Formula: | C37 H58 N9 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001184 | Name: | Dimethyl FK228 | Formula: | C26 H42 N4 O6 S2 | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | Definition date: | 2014-03-05 | Last modified: | 2023-11-03 |
|
| PRD_001189 | Name: | ATSP-7041 stapled-peptide | Formula: | C87 H124 N16 O22 | Definition date: | 2013-11-20 | Last modified: | 2023-11-03 |
|
| PRD_001198 | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | Formula: | C35 H38 Cl N5 O7 | Definition date: | 2014-10-15 | Last modified: | 2023-11-03 |
|
| PRD_001201 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide | Formula: | C29 H49 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2023-11-03 |
|
| PRD_001215 | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | Formula: | C40 H48 N7 O9 | Definition date: | 2014-05-21 | Last modified: | 2023-11-03 |
|
| PRD_000428 | Name: | CYCLOTHEONAMIDE A | Formula: | C36 H46 N9 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000456 | Formula: | C39 H67 N12 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000464 | Name: | Argadin | Formula: | C29 H41 N10 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001233 | Name: | cyclic-tris-phenylselenazole | Formula: | C36 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001234 | Name: | cyclic-tris-leucylselenazole | Formula: | C27 H36 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001235 | Name: | cyclic-tris-valinylselenazole | Formula: | C24 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001236 | Name: | cyclic-tris-alanylselenazole | Formula: | C18 H18 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|